Zebularine Treatment Induces MAGE-A11 Expression and Improves CTL Cytotoxicity Using a Novel Identified HLA-A2-restricted MAGE-A11 Peptide-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Zebularine Treatment Induces MAGE-A11 Expression and Improves CTL Cytotoxicity Using a Novel Identified HLA-A2-restricted MAGE-A11 Peptide

Published:2017-07 Issue:6 Volume:40 Page:211-220
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Zhang Jiandong,Sang Meixiang,Gu Lina,Liu Fei,Li Weijing,Yin Danjing,Wu Yunyan,Liu Shina,Huang Weina,Shan Baoen

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference45 articles.

1. Efficient lysis of epithelial ovarian cancer cells by MAGE-A3-induced cytotoxic T lymphocytes using rAAV-6 capsid mutant vector;Batchu;Vaccine,2014

2. Potential role of 5-aza-2’-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer;Gunda;Surgery,2013

3. Induction of antigen-specific immune responses by dendritic cells transduced with a recombinant lentiviral vector encoding MAGE-A3 gene;Lin;J Cancer Res Clin Oncol,2014

4. Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcoma;Li;Oncotarget,2014

5. Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results;Vansteenkiste;J Clin Oncol,2013

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting one‐carbon metabolism for cancer immunotherapy;Clinical and Translational Medicine;2024-01

2. Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy;International Journal of Molecular Sciences;2023-09-28

3. Blockade of TIM-3 and PD-1 enhances the antitumor effects of MAGE-A11 antigen-specific cytotoxic T lymphocytes;Bulletin du Cancer;2022-09

4. RGD engineered dendrimer nanotherapeutic as an emerging targeted approach in cancer therapy;Journal of Controlled Release;2021-12

5. Epigenetic Regulation of Immunotherapy Response in Triple-Negative Breast Cancer;Cancers;2021-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3